Alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role

Anaesthesia

Volumn 54, Issue 2, 1999, Pages 146-165

  Khan, Z P ^a,b   Ferguson, C N ^a   Jones, R M ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

Author keywords

Receptors; alpha 2, imidazoline

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIHYPERTENSIVE AGENT; CLONIDINE; DEXMEDETOMIDINE; IMIDAZOLINE RECEPTOR; MIVAZEROL;

ANTINOCICEPTION; BLOOD PRESSURE REGULATION; BRADYCARDIA; CHRONIC PAIN; CONTROL; DRUG EFFICACY; HEMODYNAMICS; HIGH RISK PATIENT; HYPOTENSION; ISCHEMIA; PERIOPERATIVE PERIOD; REVIEW; WAKEFULNESS;

ADJUVANTS, ANESTHESIA; ADRENERGIC ALPHA-AGONISTS; ANALGESIA; ANESTHESIA; ANIMALS; HEMODYNAMIC PROCESSES; HUMANS; IMIDAZOLES; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, DRUG;

EID: 0032905215     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2044.1999.00659.x     Document Type: Review

References (215)

1. Hieble JP, Ruffolo RR. Possible structural and functional relationships between imidazoline receptors and alpha 2-adrenoceptors. Annals of the New York Academy of Sciences 1995; 763: 8-21.
2. Ahlquist RP. A study of the adrenotropic receptors. American Journal of Physiology 1948; 153: 586-9.
3. Paton WD, Vizi ES. The inhibitory action of noradrenaline and adrenaline on acerylcholine output by guinea-pig ileum longitudinal muscle strip. British Journal of Pharmacology 1969; 35: 10-28.
4. Delbarre B, Schmitt H. A further attempt to characterize sedative receptors activated by clonidine in chickens and mice. European Journal of Pharmacology 1973; 22: 355-9.
5. Langer SZ. Presynaptic regulation of catecholamine release. Biochemical Pharmacology 1974; 23: 1793-800.
6. 3H-acetylcholine in the rabbit lacrimal gland its release by electrical field stimulation. Acta Physiologica Scandinavica 1979; 468 (Suppl.): 1-89.
7. Anden NE, Corrodi H, Fuxe K, Hokfelt B, Hokfelt T, Rydin C. Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sciences 1970; 9: 513-23.
8. 2-adrenoceptors. European Journal of Pharmacology 1982; 84: 79-85.
9. 2-adrenergic receptor. Science 1987; 238: 650-6.
10. Regan JW, Kobilka TS, Yang-Feng TL, Caron MG, Lefkowitz RJ, Kobilka BK. Cloning and expression of a human kidney cDNA for an alpha 2-adrenergic receptor subtype. Proceedings of the National Academy of the Sciences of the United States of America 1988; 85: 6301-5.
11. Lomasney JW, Lorenz W, Allen LF et al. Expansion of the alpha 2-adrenergic receptor family. Proceedings of the National Academy of the Sciences of the United States of America 1990; 87: 5094-8.
12. Matsui H, Lefkowitz RJ, Caron MG, Regan JW. Localization of the fourth membrane scanning domain as a ligand binding site in the human platelet alpha 2 adrenergic receptor. Biochemistry 1989; 28: 4125-30.
13. Gilman AG. G proteins: transducers of receptor-generated signals. Annual Review of Biochemistry 1987; 56: 615-49.
14. Freissmuth M, Casey PJ, Gilman AG. G proteins control diverse pathways of transmembrane signalling. Faseb Journal 1989; 3: 2125-31.
15. Neer EJ, Clapham DE. Roles of G protein subunits in transmembrane signalling. Nature 1988; 333: 129-34.
16. Birnbaumer L, Abramowitz J, Brown AM. Receptor-effectors coupling by G proteins. Biochimica et Biophysica Acta 1990; 1031: 163-224.
17. Codina J, Yatani A, Grenet D, Brown AM, Birnbaumer L. The subunit of the GTP binding protein Gk opens atrial potassium channels. Science 1987; 236: 442-5.
18. 2-adrenoceptor-mediated hyperpolarization of locus coeruleus neurons: Intracellular studies in vivo. Science 1982; 215: 1394-6.
19. Lipscombe D, Kongsamut S, Tsien RW. α-adrenergic inhibition of sympathetic neurotransmitter release mediated by modulation of N-type calcium-channel gating. Nature 1989; 340: 639-42.
20. o, regulates neuronal calcium channels. Nature 1987; 325: 445-7.
21. + exchange in neuroblastoma x glioma cells. Journal of Biological Chemistry 1987; 262: 6720-87.
22. Langer SZ. Presynaptic regulation of the release of catecholamines. Pharmacology Review 1981; 32: 337-62.
23. 2-adrenoceptor agonists? Anesthesiology 1992; 76: 873-5.
24. Aston-Jones G, Ennis M, Pieribone VA, Nicoll WT, Shipley MT. The brain nucleus locus coeruleus: restricted afferent control of a broad efferent network. Science 1986; 234: 734-7.
25. Esler M, Zweifler A, Randall O, Julius S, de Quattro V. Agreement among three different indices of sympathetic nervous system activity in essential hypertension. Mayo Clinic Proceedings 1977; 52: 379-82.
26. 2-adrenergic receptors in the rostral ventrolateral medulla. Hypertension 1988; 6 (Suppl. 4): S554-7.
27. Bousquet P, Feldman J, Bloch R, Schwartz J. The nucleus reticularis lateralis, a region highly sensitive to clonidine. European Journal of Pharmacology 1981; 69: 389-92.
28. Bousquet P, Feldman J, Schwartz J. Central cardiovascular effects of α-adrenergic drugs: difference between catecholamines and imidazolmes. Journal of Pharmacology and Experimental Therapeutics 1984; 230: 230-6.
29. 2-adrenoceptors in the ventrolateral medulla. European Journal of Pharmacology 1987; 134: 1-13.
30. 2-adrenoceptors and imidazoline binding sites: distribution of imidazoline binding sites in rat brain. Brain Research 1990; 514: 15-21.
31. Ernsberger P, Graves ME, Graff LM et al. I1-imidazoline receptors. Definition, characterization, distribution, and transmenibrane signalling. Annals of the New York Academy of Sciences 1995; 763: 22-42.
32. 2-adrenergic receptor or a new receptor? European Journal of Pharmacology 1990; 183: 853-4.
33. Petrusewica J, Kaliszan R. Human blood platelet alpha adrenoceptor in view of the effects of various imidazol(in)e drugs on aggregation. General Pharmacology 1991; 22: 819-23.
34. Diamant S, Eldar-Geva T, Atlas D. Imidazoline binding sites in human placenta: evidence for heterogeneity and a search for physiological function. British Journal of Pharmacology 1992; 106: 1019-27.
35. 2-adrenergic binding sites in basolateral membranes from human kidneys. European Journal of Pharmacology 1991; 206: 23-31.
36. Regunathan S, Meeley MP, Reis DJ. Expression on nonadrenergic imidazoline sites in chromaffin cell and mitochondrial membranes of bovine adrenal medulla. Biochemical Pharmacology 1993; 45: 1667-75.
37. Regunathan S, Evinger MJ, Meeley MP, Reis DJ. Effect of clonidine and other imidazole-receptor binding agents on second messenger systems and calcium influx in bovine adrenal chromaffin cells. Biochemical Pharmacology 1991; 42: 2011-18.
38. Regunathan S, Feinstein DL, Reis DJ. Expression of noradrenergic sites in rat cerebral cortical astrocytes. Journal of Neuroscience Research 1993; 34: 681-8.
39. Li G, Regunathan S, Barrow CJ, Eshraghi J, Cooper R, Reis DJ. Agmatine: an endogenous clonidine displacing substance in the brain. Science 1994; 263: 966-9.
40. Regunathan S, Reis DJ. Imidazoline receptors and their endogenous ligands. Annual Review of Phamacology and Toxicology 1996; 36: 511-44.
41. Mammoto T, Kamibayashi T, Hayashi Y, Yamatodani A, Takada K, Yoshiya I. Antiarrhythmic action of rilmenidine on adrenaline-induced arrhythmia via central imidazoline receptors in halothane-anaesthetized dogs. British Journal of Pharmacology 1996; 117: 1744-8.
42. Mest HJ, Thomson P, Raap A. Antiarrhythmic effect of the selective I1-imidazoline receptor modulator moxonidine on ouabain-induced cardiac arrhythmia in guinea pigs. Annals of the New York Academy of Sciences 1995; 763: 620-33.
43. Ostermann G, Brisgand B, Schmitt J, Fillastre JP. Efficacy and acceptability of rilmenidine for mild to moderate systemic hypertension. American Journal of Cardiology 1988; 61: 76D-80D.
44. Galley P, Manciet G, Hessel JL, Michel JP. Antihypertensive efficacy and acceptability of rilmenidine in elderly hypertensive patients. American Journal of Cardiology 1988; 61: 86D-90D.
45. Mpoy M, Vandeleene B, Ketelslegers JM, Lambert A. Treatment of systemic hypertension in insulin-treated diabetes mellitus with rilmenidine. American Journal of Cardiology 1988; 61: 91D-94D.
46. Lins R, Daelemans R, Dratwa M et al. Acceptability of rilmenidine and long-term surveillance of plasma concentration in hypertensive patients with renal insufficiency. American Journal of Medicine 1989; 87 (Suppl. 3C): 41S-45S.
47. Trimarco B, Rosiello G, Sarno D et al. Effects of one-year treatment with rilmenidine on systemic hypertension-induced left ventricular hypertrophy in hypertensive patients. American Journal of Cardiology 1994; 74: 36A-42A.
48. Li P, Penner SB, Smyth DD. Attenuated renal response to moxonidine and rilmenidine on kidney one-clip hypertensive rats. British Journal of Pharmacology 1994; 112: 200-6.
49. Dallocchio M, Gosse F, Grollier G, Morand P, Drici M, Corcoran C. La rilmenidine, un nouvel antihypertenseur dans le traitement de premiere intention de l'hypertension arterielle essenteille: etude multicentrique en double aveugle contre atenolol. Presse Medicale 1991; 20: 1265-71.
50. The UK Working Party on Rilmenidine. Rilmenidine in mild to moderate essential hypertension: a double blind, randomized, parallel group, multicenter comparison with methyldopa in 157 patients. Clinical Therapeutics Research 1990; 47: 194-211.
51. MacPhee GJA, Howie CA, Elliott HL, Reid JL. A comparison of the haemodynamic and behavioural effects of moxonidine and clonidine in normotensive subjects. British Journal of Clinical of Pharmacology 1992; 33: 261-7.
52. Prichard BNC, Simmons R, Rooks MJ, Haworth DA, Laws D, Wonnacott S. A double-blind comparison of moxonidine and atenolol in the management of patients with mild to moderate hypertension. Journal of Cardiovascular Pharmacology 1992; 20 (Suppl. 4): S45-S49.
53. Wolf R. The treatment of hypertensive patients with a calcium antagonist or moxonidine: a comparison. Journal of Cardiovascular Pharmacology 1992; 20 (Suppl. 4): S42-S44.
54. Ollivier JP, Christen MO, Schafer SG. Moxonidine: a second generation of centrally acting drugs. An appraisal of clinical experience. Journal of Cardiovascular Pharmacology 1992; 20 (Suppl. 4): S31-S37.
55. Planitz V. Infra-individual comparison of moxonidine and prazosin in hypertensive patients. European Journal of Clinical Pharmacology 1986; 229: 645-50.
56. 2-adrenoceptors in the human central nervous system. Neurosciences 1994; 59: 589-98.
57. 2A-adrenoceptors. European Journal of Pharmacology 1989; 167: 95-104.
58. 3H] rauwolscine? A comparison of nine tissue and cell lines. Journal of Pharmacology and Experimental Therapeutics 1995; 273: 1287-94.
59. 2 adrenergic receptors: binding studies on different human and rat membrane preparations. Neurochemistry International 1994; 24: 221-9.
60. 2-adrenoceptor agonist effects by atipamezole in human volunteers. British Journal of Clinical Pharmacology 1991; 31: 160-5.
61. Dyck JB, Shafer SL. Dexmedetomidine pharmacokinetics and pharmacodynamics. Anaesthetic Pharmacology Review 1993; 1: 238-45.
62. Leimdorfer A. The action of sympathomimetic amines on the central nervous system and the blood sugar: relation of chemical structure to mechanism of action. Journal of Pharmacology and Experimental Therapeutics 1950; 98: 62-71.
63. Feldberg W, Sherwood SL. Injections of drugs into the lateral ventricle of the cat. Journal of Physiology 1954; 123: 148-67.
64. Grunden LR. Action of intracerebroventricular epinephrine on gross behavior, locomotor activity and hexobarbital sleeping times in rats. International Journal of Neuropharmacology 1969; 8: 573-86.
65. Fugner A, Hoefke W. Asleep-like in chicks caused by biogenic amines and other compounds, quantitative evaluation. Arzneimittel-Forschung 1971; 21: 1243-7.
66. Lidbrink P. The effect of lesion of ascending noradrenaline pathways on sleep and waking in the rat. Brain Research 1974; 74: 19-40.
67. Hossman V, Maling TJB, Hamilton CA, Reid JL, Dollery CT. Sedative and cardiovascular effects of clonidine and nitrazepam. Clinical Pharmacology and Therapeutics 1980; 28: 167-76.
68. Ferrari F, Tartoni PL, Margiafico V. B-HT 920 antagonizes rat neophobia in the X-maze test. Archives of International Pharmacodynamics and Therapeutics 1989; 298: 7-14.
69. Soderpalm B, Engel JA. Biphasic effects of clonidine on conflict behavior. Involvement of different α-adrenoceptors. Pharmacology, Biochemistry and Behavior 1988; 30: 471-7.
70. 2-agonist, on cerebral blood flow and oxygen consumption during halothane anesthesia in dogs. Anesthesia and Analgesia 1990; 71: 125-9.
71. 2-adrenergic agonist decreases cerebral blood flow in the isoflurane anesthetized dog. Anesthesia and Analgesia 1990; 70: 624-30.
72. 2-adrenoceptor agonist dexmedetomidine in a focal model of cerebral ischaemia. Anesthesiology 1993; 79: 306-12.
73. Ruffolo RR Jr Distribution and function of peripheral α-adrenoceptors on the cardiovascular system. Pharmacology, Biochemistry and Behavior 1985; 22: 827-33.
74. Nichols AJ. Alpha-adrenoceptor signal transduction mechanisms, alpha-adrenoceptors. In: Ruffolo RRJr, ed. Molecular Biology, Biochemistry and Pharmacology. New York: Karger, 1991: 44-74.
75. Bloor BC, Frankland M, Alper G, Raybould D, Weitz J, Shurtliff M. Hemodynamic and sedative effects of dexmedetomidine in dog. Journal of Pharmacology and Experimental Therapeutics 1992; 263: 690-7.
76. Tibirica E, Feldman J, Mermet C, Gonon F, Bousquet P. An imidazoline specific mechanism for the hypotensive effect of clonidine. A study with yohimbine and idazoxan. Journal of Pharmacology and Experimental Therapeutics 1991; 256: 606-13.
77. Badoer E, Head GA, Korner PI. Effects of intracisternal and intravenous alpha-methyldopa and clonidine on haemodynamics and baroreceptor-heart rate reflex properties in conscious rabbits. Journal of Cardiovascular Pharmacology 1983; 5: 760-7.
78. 2 adrenoceptors in the bradycardic effects of clonidine and analogues. Naunyn-Schmiedebergs Archives of Pharmacology 1981; 317: 8-12.
79. 2-adrenoceptors in halothane-anesthetized dogs. Anesthesiology 1991; 75: 113-17.
80. Zochowski RJ, Lada W. Intravenous clonidine in acute myocardial infarction in men. International Journal of Cardiology 1984; 6: 189-201.
81. Angus JA, Cocks TM, Satoh K. Alpha 2-adrenoceptors and endothelium-dependent relaxation in canine large arteries. British Journal of Pharmacology 1986; 88: 767-77.
82. 2-adrenergic receptor subtypes on pig endothelial cell. FASEB Journal 1992; 6: A1556 (Abstract).
83. Coughlan MG, Lee JG, Bosnjak ZJ, Schmeling WT, Kampine JP, Warltier DC. Direct coronary and cerebral vascular responses to dexmedetomidine. Significance of endogenous nitric oxide synthesis. Anesthesiology 1992; 77: 998-1006.
84. Ooi R, Pattison J, Feldman SA. The effects of intravenous clonidine on ventilation. Anaesthesia 1991; 46: 632-3.
85. Nguyen D, Abdul-Rasool I, Ward D et al. Ventilatory effects of dexmedetomidine, atipamezole, and isoflurane in dogs. Anesthesiology 1992; 76: 573-9.
86. Belleville JP, Ward DS, Bloor BC, Maze M. Effects of intravenous dexmedetomidine in humans. Anesthesiology 1992; 77: 1125-33.
87. Bailey PL, Sperry RJ, Johnson GK et al. Respiratory effects of clonidine alone and combined with morphine, in humans. Anesthesiology 1991; 74: 43-8.
88. Jarvis DA, Duncan SR, Segal IS, Maze M. Ventilatory effects of clonidine alone and in the presence of alfentanil, in human volunteers. Anesthesiology 1992; 76: 899-905.
89. Smyth DD, Umemura S, Pettinger WA. Alpha 2-adrenoceptor antagonism of vasopressin-induced changes in sodium excretion. American Journal of Physiology 1985; 248: F767-72.
90. Pettinger WA. Renal alpha 2-adrenergic receptors and hypertension. Hypertension 1987; 9: 3-6.
91. Chen M, Lee J, Huang BS, Grekin RJ, Malvin RL. Clonidine and morphine increase atrial natriuretic peptide secretion in anaesthetized rats. Proceedings of the Society for Experimental Biology and Medicine 1989; 191: 299-303.
92. Hokfelt B, Hedeland H, Hansson B-G. The effect of clonidine and penbutolol, respectively on catecholamines in blood and urine, plasma renin activity and urinary aldosterone in hypertensive patients. Archives of International Pharmacodynamics 1975; 213: 307-21.
93. 2-adrenoteptors. European Journal of Pharmacology 1988; 154: 191-6.
94. 2-adrenoceptor agonists stimulate growth hormone secretion but have no acute effects on plasma cortisol under basal conditions. Hormone Research 1987; 25: 65-71.
95. Masal A, Satta G, Alagna S et al. Effect of clonidine on stress-induced cortisol release during surgery. Pharmacological Research Communications 1985; 17: 293-8.
96. Di Joseph JF, Taylor JA, Mir GN. Alpha-2 receptors in the gastrointestinal system: a new therapeutic approach. Life Sciences 1984; 35: 1031-42.
97. McArthur KE, Anderson DS, Durbin TE, Orloff MJ, Dharmsathaphorn K. Clonidine and lidamidine to inhibit watery diarrhea in a patient with lung cancer. Annals of Internal Medicine 1982; 96: 323-5.
98. 2 receptor-mediated effects of clonidine. Clinical Pharmacology and Therapeutics 1980; 28: 605-10.
99. Grant JA, Scrutton MC. Interaction of selective alpha-adrenoceptor agonists and antagonists with human and rabbit blood platelets. British Journal of Pharmacology 1980; 71: 121-34.
100. Radomski MW, Palmer RM, Moncada S. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. British Journal of Pharmacology 1987; 92: 639-46.
101. 2-adrenergic agonists and benzodiazepines in rats. Anesthesiology 1992; 76: 1004-11.
102. Horvath G, Szikszay M, Benedek G. Calcium channels are involved in the hypnotic-anesthetic action of dexmedetomidine in rats. Anesthesia and Analgesia 1992; 74: 884-8.
103. Roizen MF. Should we all have a sympathectomy at birth - or at least preoperatively. Anesthesiology 1988; 68: 482-4.
104. Kulka PJ, Tryba M, Zenz M. Dose-response effects of intravenous clonidine on stress response during induction of anesthesia in coronary artery bypass graft patients. Anesthesia and Analgesia 1995; 80: 263-8.
105. Dorman BH, Zucker J, Verrier ED, Gartman DM, Slachman FN. Clonidine improves perioperative myocardial ischemia, reduces anesthetic requirements, and alters hemodynamic parameters in patients undergoing coronary artery bypass surgery. Journal of Cardiothoracic and Vascular Anesthesia 1993; 7: 386-95.
106. De Kock M, Versailles H, Colinet B, Karthaeuser R, Scholtes JL. Epidemiology of the adverse events occuring during 'Clonidine anesthesia': a prospective open trial of intravenous clonidine. Journal of Clinical Anesthesia 1995; 7: 403-10.
107. De Kock M, Famenne F, Deckers G, Scholtes JL. Epidural clonidine or sufentanil for intraoperative and postoperative analgesia. Anesthesia and Analgesia 1995; 81: 1154-62.
108. Akistopolou H, Whitwam JG, Al-Khudhairi D et al. Acute tolerance to tentanyl during anesthesia in dogs. Anesthesiology 1985; 63: 255-9.
109. Bernard JM, Bourreli B, Hommeril. JL, Pinaud M. Effects of oral clonidine premedication and postoperative i.v. infusion on haemodynamic and adrenergic responses during recovery from anaesthesia. Acta Anaesthesiologica Scandinavica 1991; 35: 54-9.
110. Ceremuzynski L, Zaleska T, Lada W, Zalewski A. Clonidine eftect in chronic angina pectoris. Double-blind, crossover trial on, 60 patients. European Journal of Cardiology 1979; 10: 415-27.
111. Thomas MG, Quiroz AC, Rice JC, Sander GE, Giles TD. Antianginal effects of clonidine. Journal of Cardiovascular Pharmacology 1986; 8: S69-75.
112. Cocco G, Strozzi C, Haeusler G, Chu D, Amrein R, Radovan GC. Therapeutic value of clonidine in patients with coronary heart disease. European Journal of Cardiology 1979; 10: 221-8.
113. Tanaka M, Nishikawa T. Oral clonidine premedication attenuates the hypertensive response to ketamine. British Journal of Anaesthesia 1994; 73: 758-62.
114. Talke P, Li J, Jain U et al. Effects of perioperative dexmedetomedine infusion in patients undergoing vascular surgery. Anesthesiology 1995; 82: 620-33.
115. 2-adrenoceptor agonist. Cardiovascular Drugs and Therapy 1993; 7: 929-34.
116. 2-adrenoceptor agonist mivazerol on hemodynamic stability and myocardial ischemia. Anesthesiology 1997; 86: 346-63.
117. Aantaa R, Kanto J. Is clonidine an anaesthetic in man? Anaesthesia 1992; 47: 533.
118. Walland A. Clonidine. In: Goldberg ME, ed. Pharmacological and Biochemical Properties of Drug Substances. Washington DC: American Pharmaceutical Association, 1977: 67-107.
119. Carabine UA, Wright PMC, Moore J. Preanaesthetic medication with clonidine: a dose response study. British Journal of Anaesthesia 1991; 67: 79-83.
120. Mikawa K, Maekawa N, Nishina K, Takao H, Yaku H, Obara H. Efficacy of oral clonidine premedication in children. Anesthesiology 1993; 79: 926-31.
121. Flacke JW, Bloor BC, Flacke WE et al. Reduced narcotic requirement by clonidine with improved hemodynamic and adrenergic stability in patients undergoing coronary bypass surgery. Anesthesiology 1987; 67: 909-17.
122. Scheinin H, Jaakola M-L, Sjovall S et al. Intramuscular dexmedetomidine as premedication for general anesthesia. Anesthesiology 1993; 78: 1065-75.
123. Handley SL, Mithani S. Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour. Naunyn-Schmiedebergs Archives of Pharmacology 1984; 327: 1-5.
124. Salonen M, Onaivi ES, Maze M. Dexmedetomidine synergism with midazolam in the elevated plus-maze test in rats. Psychopharmacology (Berlin) 1992; 108: 229-34.
125. Miller RD, Way WL, Eger EI. The effects of alpha-methyldopa, reserpine, guanethidine and iproniazid on minimum alveolar anesthetic requirement (MAC). Anesthesiology 1968; 29: 1153-8.
126. Brodsky JB, Bravo JJ. Acute postoperative clonidine withdrawal syndrome. Anesthesiology 1976; 44: 519-20.
127. Kaukinen S, Kaukinen L, Eerola R. Postoperative use of clonidine with neuroleptanaesthesia. Acta Anaesthesiologica Scandinavica 1979; 23: 113-20.
128. Kaukinen S, Pyykko K. The potentiation of halothane anesthesia by clonidine. Acta Anaesthesiologica Scandanivica 1979; 23: 107-11.
129. Bloor BC, Flacke WE. Reduction in halothane anesthetic requirement by clonidine, an alpha adrenergic agonist. Anesthesia and Analgesia 1982; 61: 741-5.
130. Orko R, Pouttu J, Ghignone M, Rosenberg PH. Effect of clonidine on haemodynamic responses to endotracheal intubation and on gastric acidity. Acta Anaesthesiologica Scandinavica 1987; 31: 325-9.
131. Roizen MF, White PF, Eger EI, Brownstein M. Effects of ablation of serotonin or norepinephrine brain stem areas on halothane and cyclopropane MACs in rats. Anesthesiology 1978; 78: 252-5.
132. 2-adrenergic receptor. Anesthesiology 1988; 69: 818-23.
133. Ghignone M, Quintin L, Duke PC, Kehler CH, Calvillo O. Effects of clonidine on narcotic requirements and hemodynamic response during induction of fentanyl anesthesia and endotracheal intubation. Anesthesiology 1986; 64: 36-42.
134. Ghignone M, Calvillo O, Quintin L. Anesthesia and hypertension: The effect of clonidine on preoperative hemodynamics and isoflurane requirements. Anesthesiology 1987; 67: 3-10.
135. Abi-Jaoude F, Brusset A, Ceddaha A et al. Clonidine premedication for coronary artery bypass grafting under high dose alfentanil anesthesia: intraoperative and postoperative hemodynamic study. Journal of Cardiothoracic and Vascular Anesthesia 1993; 7: 35-40.
136. Segal IS, Jarvis DA, Duncan SR, White PF, Maze M. Clinical efficacy of oral transdermal clonidine combinations during the perioperative period. Anesthesiology 1991; 74: 220-5.
137. Kharasch ED, Hill HF, Eddy AC. Influence of dexmedetomidine and clonidine on human liver alfentanil metabolism. Anesthesiology 1991; 75: 520-4.
138. Aho M, Erkola O, Kallio A, Scheinin H, Korttila K. Dexmedetomidine infusion for maintenance of anesthesia in patients undergoing abdominal hysterectomy. Anesthesia and Analgesia 1992; 75: 940-6.
139. Scheinin B, Lindgren I, Randell T, Scheinin H, Scheinin M. Dexmedetomidine attenuates sympathoadrenal responses to tracheal intubation and reduces the need for thiopentone and perioperative fentanyl. British Journal of Anaesthesia 1992; 68: 126-31.
140. Paalzow L. Analgesia produced by clonidine in mice and rats. Journal of Pharmacy and Pharmacology 1974; 26: 361-3.
141. Fields HL, Basbaum AI. Brainstem control of spinal neurones. Annual Review of Physiology 1978; 40: 217-48.
142. Mayer DJ, Liebskind JC. Pain reduction by focal electrical stimulation of the brain: an anatomical and behavioral analysis. Brain Research 1974; 68: 73-93.
143. Marwaha J, Kehne JH, Commissaris RL, Lakoski J, Shaw W, Davis M. Spinal clonidine inhibits neural firing in locus coeruleus. Brain Research 1983; 276: 379-82.
144. Alojado ES, Ohta Y, Kemmotsu O. The effect of clonidine on the activity of neurons in the rat dorsal raphe nucleus in vitro. Anesthesia and Analgesia 1994; 79: 257-60.
145. Jones SL, Gebhart GF. Characterization of coeruleus inhibition of the nociceptive tail-flick reflex in the rat: mediation by spinal 2-adrenoreceptor. Brain Research 1986; 364: 315-30.
146. Howe JR, Wan J-Y, Yaksh TL. Selective antagonism of the antinociceptive effect of intrathecally applied alpha adrenergic agonists by intrathecal prazosin and intrathecal yohimbine. Journal of Pharmacology and Experimental Therapeutics 1983; 224: 552-8.
147. Kuraishi Y, Hirota N, Sato Y, Kaneko S, Satoh M, Takagi H. Noradrenergic inhibition of the release of substance P from primary afferents in rabbits spinal dorsal horn. Brain Research 1985; 359: 177-82.
148. Murata K, Nakagawe I, Kumeta Y, Kitahata LM, Collins JG. Intrathecal clonidine suppresses noxiously evoked activity of spinal wide dynamic range neurons in cats. Anesthesia and Analgesia 1989; 69: 185-91.
149. Bouaziz H, Hewitt C, Eisenach JC. Subarachnoid neostigmine potentiation of alpha, 2-adrenergic agonist analgesia. Regional Anesthesia 1995; 20: 121-7.
150. 2-adrenergic agonists stimulate acetylcholine and norepinephrine release from the spinal cord dorsal horn in sheep. An in vivo microdialysis study. Anesthesiology 1997; 87: 110-16.
151. Eisenach J, Detweiler D, Hood D. Hemodynamic and analgesic actions of epidurally administered clonidine. Anesthesiology 1993; 78: 277-87.
152. Post C, Gordh T, Milnor BG, Archer T, Freedman J. Antinociceptive effects and spinal cord tissue concentrations after intrathecal guanfacine or clonidine into rats. Anesthesia and Analgesia 1987; 66: 317-24.
153. 2-adrenergic agonists. Anesthesiology 1991; 74: 766-71.
154. Coote JH. The organisation of cardiovascular neurons in the spinal cord. Review of Physiology, Biochemistry and Pharmacology 1988; 110: 148-277.
155. Castro MI, Eisenach JC. Pharmacokinetics and dynamics of intravenous, intrathecal, and epidural clonidine in sheep. Anesthesiology 1989; 71: 418-25.
156. Gordh T Jr Epidural clonidine for treatment of postoperative pain after thoracotomy. A double-blind placebo-controlled study. Acta Anaesthesiologica Scandinavica 1988; 32: 702-9.
157. Priddle HD, Andros GJ. Primary spinal anesthetic effects of epinephrine. Anesthesia and Analgesia 1950; 29: 156-61.
158. Bernard JM, Hommeril JL, Passuti N, Pinaud M. Postoperative analgesia by intravenous clonidine. Anesthesiology 1991; 75: 577-82.
159. Aho M, Erkola O, Scheinin H, Lehtinen AM, Korttila K. Effect of intravenously administered dexmedetomidine on pain after laparoscopic tubal ligation. Anesthesia and Analgesia 1991; 73: 112-18.
160. Tamsen A, Gordh T. Epidural clonidine produces analgesia. Lancet 1984; 2: 231-2.
161. Bonnet F, Boico O, Rostaing S et al. Postoperative analgesia with extradural clonidine. British Journal of Anaesthesia 1989; 63: 465-9.
162. Rockermann MG, Seeling W, Brinkmann A et al. Analgesic and hemodynamic effects of epidural clonidine, clonidine/morphine, and morphine after pancreatic surgery. Anesthesia and Analgesia 1995; 80: 869-74.
163. Anzai Y, Nishikawa T. Thoracic epidural clonidine and morphine for postoperative pain relief. Canadian Journal of Anaesthesia 1995; 42: 292-7.
164. Cigarini I, Kaba A, Bonnet F et al. Epidural clonidine combined with bupivacaine for analgesia in labor. Regional Anesthesia 1995; 20: 113-20.
165. Eisenach JC, Lysak SZ, Vkiscomin CM. Epidural clonidine following surgery; phase I. Anesthesiology 1989; 71: 640-6.
166. Rostaing S, Bonnet F, Levron J, Vodinh J, Pluskwa F, Saada M. Effect of epidural clonidine on analgesia and pharmacokinetics of epidural fentanyl in postoperative patients. Anesthesiology 1991; 75: 420-5.
167. Bernard JM, Kick O, Bonnet F. Comparison of intravenous and epidural clonidine for postoperative patient-controlled analgesia. Anesthesia and Analgesia 1995; 81: 706-12.
168. Coombs DW, Saunders RL, Lachance D. Intrathecal morphine tolerance. Use of intrathecal clonidine, DADLE, and intraventricular morphine. Anesthesiology 1985; 62: 358-63.
169. Klinischa W, Chiari A, Krafft P et al. Hemodynamic and analgesic effects of clonidine added repetitively to continuous epidural and spinal blocks. Anesthesia and Analgesia 1995; 80: 322-7.
170. Grace D, Bunting H, Milligan KR, Fee JPH. Postoperative analgesia after co-administration of clonidine and morphine by the intrathecal route in patients undergoing hip replacement. Anesthesia and Analgesia 1995; 80: 86-91.
171. Racle JP, Benkhadra A, Poy JY, Gleizal B. Prolongation of isobaric bupivacaine spinal anesthesia with epinephrine and clonidine for hip surgery in the elderly. Anesthesia and Analgesia 1987; 66: 442-6.
172. Filos KS, Goudas LC, Patroni O, Polyzou V. Intrathecal clonidine as a sole analgesic for pain relief after Cesarean section. Anesthesiology 1992; 77: 267-74.
173. Gordh T, Post C, Olsson Y. Evaluation of the toxicity of subarachnoid clonidine, guanfacine and a substance P antagonist on rat spinal cord and nerve roots. Anesthesia and Analgesia 1986; 65: 1303-11.
174. Fukushima K, Nishimi Y, Mori K, Takeda J. Central effect of epidurally administered dexmedetomidine on sympathetic activity and postoperative pain in man (abstract). Anesthesia and Analgesia 1996; 82: S121.
175. 2-adrenoceptor agonists clonidine and dexmedetomidine on the prevention and treatment of experimental neuropathic pain. Anesthesia and Analgesia 1993; 77: 104-9.
176. 2 adrenoceptor agonists. Journal of Pharmacology and Experimental Therapeutics 1995; 272: 207-14.
177. Leiphart JW, Cynthia V, Dills BS et al. A comparison of intrathecally administered narcotic and non-narcotic analgesics for experimental chronic
178. Lee YW, Yaksh TL. Analysis of drug interaction between intrathecal clonidine and MK-801 in peripheral neuropathic pain rat model. Anesthesiology 1995; 82: 741-8.
179. Glynn C, O'Sullivan K. A double-blind randomised comparison of the effects of epidural clonidine, lignocaine and the combination of clonidine and lignocaine in patients with chronic pain. Pain 1995; 64: 337-43.
180. Carroll D, Jadad A, King V, Wiffen P, Glynn C, McQuay H. Single dose, randomized, double-blind, double-dummy cross-over comparison of extradural and; i.v. clonidine in chronic pain. British Journal of Anaesthesia 1993; 71: 665-9.
181. Byas-Smith MG, Max MB, Muir J, Kingman A. Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two stage 'enriched enrolment'design. Pain 1995; 60: 267-74.
182. Eisenach JC, Rauck RL, Buzzanell C, Lysak SZ. Epidural clonidine analgesia for intractable cancer pain: phase, 1. Anesthesiology 1989; 71: 647-52.
183. Eisenach JC, DuPen S, Dubois N, Miguel R, Allin D. Epidural clonidine analgesia for intractable cancer pain. Pain 1995; 61: 391-9.
184. Davies KD, Treede RD, Raja SN, Meyer RA, Campbell JN. Topical application of clonidine relieves hyperalgesia in patients with sympathetically maintained pain. Pain 1991; 47: 309-17.
185. Liepert DM, Townsend GE. Improved hemodynamic and renal function with clonidine in coronary artery bypass grafting. Anesthesia and Analgesia 1990; 70: S1-S450.
186. Kulka PJ, Tryba M, Menzel C, Leurs F, Frankenberg C. Preoperative clonidine improves postoperative renal function in CABG patients. British Journal of Anaesthesia 1993; 70 (Suppl. 1): A143.
187. 2 during recovery from anaesthesia. British Journal of Anaesthesia 1968; 40: 398-406.
188. Macintyre PE, Pavlin EG, Dwersteg JF. Effect of meperidine on oxygen consumption, carbon dioxide production, and respiratory gas exchange in postanaesthesia shivering. Anesthesia and Analgesia 1987; 66: 751-5.
189. Flacke JW, Flacke WE. Inadvertent hypothermia: frequent, insidious, and often serious. Seminars in Anesthesia 1983; 2: 183-96.
190. Guffin A, Girard D, Kaplan JA. Shivering following cardiac surgery: hemodynamic changes and reversal. Journal of Cardiothoracic Anesthesia 1987; 1: 24-8.
191. Delaunay L, Bonnet F, Duvaldestin P. Clonidine decreases postoperative oxygen consumption in patients recovering from general anaesthesia. British Journal of Anaesthesia 1991; 67: 397-401.
192. Goldfarb G, Ang ET, Debaene B, Khon S, Jolis P. Effect of clonidine on postoperative shivering in man: a double blind study. Anesthesiology 1989; 71: A650.
193. Schmelling WT, Kampine JP, Warltier DC. Dexmedetomidine attenuates the 'shivering' upon emergence from halothane anesthesia in chronically instrumented cats. Anesthesia and Analgesia 1992; 74: S264.
194. Ghignone M, Noe C, Calvillo O, Quintin L. Anesthesia for ophthalmic surgery in elderly; the effects of clonidine on intraocular pressure, perioperative hemodynamics and anesthetic requirement. Anesthesiology 1988; 68: 707-16.
195. Krieglstein GK, Langham ME, Leydhecker W. The peripheral and central neural, actions of clonidine in normal and glaucomatous eyes. Investigative Ophthalmology and Visual Science 1978; 17: 149-58.
196. Virkilla M, Ali-Melkkila T, Kanto J, Turunen J, Scheinin H. Dexmedetomidine as intramuscular premedication in outpatient cataract surgery. Anaesthesia 1993; 48: 482-7.
197. Clarke KW, Hall LW. Xylazine - a new sedative for horses and cattle. Veterinary Record 1969; 85: 512-17.
198. Hsu WH. Xylazine induced depression and its antagonism by alpha-adrenergic blocking agents. Journal of Pharmacology and Experimental Therapeutics 1981; 218: 188-92.
199. Haskins SC, Peiffer RL Jr, Stowe RM. A clinical comparison of CT 1341, ketamine, and xylazine in cats. American Journal of Veterinary Research 1975; 36: 1537-13.
200. Clarke KW, Taylor PM. Detomidine: A new sedative for horses. Equine Veterinary Journal 1986; 18: 366-70.
201. 2 adrenoceptors in the central nervous system. Acta Veterinaria Scandinavica 1989; 85: 11-19.
202. Barnett AJ, Cantor S. Observations on the hypotensive action of Catapres (St 155) in man. Medical Journal of Australia 1968; 1: 87-91.
203. Hermiller JB, Margorien RJD, Leithe ME, Unverferth DV, Leier CV. Clonidine in congestive heart failure: a vasodilator drug with negative inotropic effects. American Journal of Cardiology 1983; 51: 791-5.
204. Foresti A, Massari FM, Lotto A. Hemodynamic effects of clonidine in patients with acute myocardial infarction complicated by hypertension. Journal of Cardiovascular Pharmacology 1986; 8 (Suppl. 3): S30-2.
205. Redmond DE Jr, Huang YH. The primate locus coeruleus and effects of clonidine on opiate withdrawal. Journal of Clinical Psychiatry 1982; 43: 25-9.
206. Gold MS, Pottash AL, Sweeney DR, Kleber HD. Efficacy of clonidine in opiate withdrawal: a study of thirty patients. Drug and Alcohol Dependence 1980; 6: 201-8.
207. Ashton H. Benzodiazepine withdrawal. Outcome in 50 patients. British Journal of Addiction 1987; 82: 665-71.
208. 2-adrenergic treatment. Alcoholism 1989; 13: 361-4.
209. Davison R, Kaplan K, Fintel D, Parker M, Anderson L, Haring O. The effect of clonidine and the cessation of cigarette smoking. Clinical Pharmacology and Therapeutics 1988; 44: 265-7.
210. Glassman AH, Jackson WK, Walsh BT et al. Cigarette craving, smoking withdrawal, and clonidine. Science 1984; 226: 864-6.
211. Pearce KI. Clonidine and smoking. Lancet 1986; I: 810.
212. Zubenko GS, Cohen BM, Lipinski JF, Jonas JM. Clonidine in the treatment of mania and mixed bipolar disorder. American Journal of Psychiatry 1984; 141: 1617-18.
213. Hunt RB, Minderaa RB, Cohen DJ. Clonidine benefits children with attention deficit disorder and hyperactivity. Report of double-blind placebo-crossover therapeutic trial. Journal of the American Academy of Child and Adolescent Psychiatry 1985; 24: 617-29.
214. Jerussi TP, Capacchione JF, Benvenga MJ. Reversal of opioid-induced muscle rigidity in rats. Evidence for α-2-adrenergic involvement. Pharmacology, Biochemistry and Behavior 1987; 28: 283-9.
215. 2 adrenergic receptors. Pharmacology, Biochemistry and Behavior 1985; 22: 835-43.